Current And Emerging Therapeutic Approaches For Multiple Myeloma - Thomas Martin, Md

Current and Emerging Therapeutic Approaches for Multiple Myeloma (MM) — Thomas Martin, MD

Research To Practice

Thomas Martin, MD, on Summer Meeting Highlights in Multiple Myeloma

Blood Cancers Today

Dr. Martin Highlights Recent Myeloma Research at EHA 2024

Blood Cancers Today

Emerging Treatment Strategies in Multiple Myeloma

Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD

Dana-Farber Cancer Institute

Tom Martin, MD, Discusses Medicare and Multiple Myeloma

Emerging Immunotherapies in Multiple Myeloma

Challenges with the real-world use of CAR-T therapy in multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Genomic determinants of resistance to anti-BCMA CAR-T therapy in patients with R/R myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Current and Emerging CAR T-Cell Therapies for Myeloma

Patient Empowerment Network

Highlights of ASH: Conversation about Multiple Myeloma with Thomas Martin and Monica Soni

Onco'Zine - The International Oncology Network

Unmet needs and unanswered questions in multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Tom Martin, MD, on Promising New Research in High-Risk Multiple Myeloma

Bispecific T-cell engagers in the treatment of myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Current and emerging novel immunotherapies for myeloma

Multiple Myeloma Symposium: Emerging Treatment Options | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Future Therapies in Multiple Myeloma

Clinical Updates: Emerging Therapies for Patients With Multiple Myeloma

Approaches To Achieve the Best Possible Outcomes in Myeloma

International Myeloma Foundation

Considerations for mitigating CAR-T resistance in multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc